Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Carcinoma, Renal Cell × Sunitinib × Clear all

Phase

Status

Sponsor Class

OTHER 60 INDUSTRY 45 NIH 6 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Small Cell Lung Carcinoma 1 Lung Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

bemarituzumab 1 anlotinib 1 Sunitinib 1 Radiosurgery 1 Nivolumab 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02626754 2018-06-26

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Taipei Veterans General Hospital, Taiwan

Phase 2 Terminated

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡